Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View
Open Access
- 9 June 2020
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1790
Abstract
Starting from the work of Ulivi and colleagues, we aim to summarize the research area of biomarkers for early diagnosis and early stage lung cancer.Keywords
Funding Information
- Italian Ministry of Health with Ricerca Corrente (5x1000)
This publication has 69 references indexed in Scilit:
- Lung Cancer Signature Biomarkers: tissue specific semantic similarity based clustering of Digital Differential Display (DDD) dataBMC Research Notes, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non–Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of UrineJournal of Proteome Research, 2011
- Clinical validation of an autoantibody test for lung cancerAnnals of Oncology, 2010
- Integrated Ionization Approach for RRLC−MS/MS-based Metabonomics: Finding Potential Biomarkers for Lung CancerJournal of Proteome Research, 2010
- Cancer Biomarkers: Are We Ready for the Prime Time?Cancers, 2010
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007